Moderna (MRNA) Stock Price, News & Analysis - MarketBeat

Jan 29, 2025 · Get The Latest MRNA Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. ... Moderna (MRNA) Stock Price, News & …

CouponFollow Extension

$35.89
OFF

Moderna (MRNA) Stock Chart And Price History 2025 - MarketBeat

2 weeks from now

2 days ago · Enter your email address below to receive the latest news and analysts' ratings for Moderna and its competitors with MarketBeat's FREE daily newsletter. 01/22/2025 $35.89

marketbeat.com

12%
OFF

Moderna, Inc. (MRNA) Stock Price, Quote & News - Stock Analysis

2 weeks from now

Jan 31, 2025 · Analyst Forecast. According to 20 analysts, the average rating for MRNA stock is "Hold." The 12-month stock price forecast is $67.06, which is an increase of 70.12% from the …

stockanalysis.com

17%
OFF

Watch These Moderna Price Levels As Stock Plummets After

2 weeks from now

Jan 14, 2025 · Moderna shares will likely remain under scrutiny after plunging nearly 17% Monday as the embattled drug maker slashed its 2025 revenue forecast by $1 billion. Watch these …

investopedia.com

$32.60
OFF

Moderna, Inc. (NASDAQ:MRNA) Shares Acquired By Abrdn Plc

2 weeks from now

8 hours ago · Moderna Stock Down 3.0 %. MRNA opened at $32.60 on Friday. The company has a quick ratio of 4.20, a current ratio of 4.39 and a debt-to-equity ratio of 0.05. Moderna, Inc. …

etfdailynews.com

$108.00
OFF

Moderna (MRNA) To Release Earnings On Friday | MarketBeat

2 weeks from now

1 day ago · UBS Group dropped their target price on shares of Moderna from $108.00 to $96.00 and set a "buy" rating on the stock in a research report on Wednesday, January 8th. ... Based …

marketbeat.com

$83.09
OFF

Moderna (NASDAQ:MRNA) Stock, Analyst Ratings, Price Targets

2 weeks from now

Jan 31, 2025 · Moderna (NASDAQ:MRNA) Stock, Analyst Ratings, Price Targets, Forecasts Moderna Inc has a consensus price target of $83.09 based on the ratings of 27 analysts. The …

benzinga.com

$79.50
OFF

Analysts Set Moderna, Inc. (NASDAQ:MRNA) Target Price At $79.50

2 weeks from now

Jan 7, 2025 · Moderna, Inc. (NASDAQ:MRNA - Get Free Report) has received an average rating of "Hold" from the twenty-two research firms that are presently covering the company, …

marketbeat.com

$75.58
OFF

Moderna (NASDAQ:MRNA) Stock Price Expected To Rise

2 weeks from now

Jan 17, 2025 · According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $75.58. Get Our Latest Analysis on Moderna Moderna Trading …

marketbeat.com

12%
OFF

Moderna Stock Jumps 12%: Sell The News Or Buy The Future?

2 weeks from now

Jan 8, 2025 · The analyst forecasts on MarketBeat have a consensus price target of $79.50 on MRNA stock. That gives the stock nearly 77% upside from the closing price on January 7. …

marketbeat.com

$33.31
OFF

Is Moderna Stock A Buy? Breaking Down The Latest Guidance

2 weeks from now

Jan 22, 2025 · MRNA is nearing the apex point, at which time it should break to the downside or the upside depending on which trendline it pierces. (Fib) pullback support levels are at $33.31, …

marketbeat.com

33%
OFF

Spire Wealth Management Purchases 22,192 Shares Of Moderna

2 weeks from now

3 days ago · Institutional investors own 75.33% of the company's stock. Insider Buying and Selling at Moderna. In other Moderna news, insider Shannon Thyme Klinger sold 1,418 shares …

marketbeat.com

$4.71
OFF

Moderna (MRNA) Earnings Date And Reports 2025 - MarketBeat

2 weeks from now

Moderna (NASDAQ:MRNA) has a recorded net income of -$4.71 billion. ... Check stock news, ratings, SEC filings, and more. ... Stay informed with MarketBeat's real-time news. Export data …

marketbeat.com

$153.59
OFF

Promising Biotech Stocks To Add To Your Watchlist - MarketBeat

2 weeks from now

4 days ago · The stock has a market cap of $153.59 billion, a price-to-earnings ratio of 40.25, a price-to-earnings-growth ratio of 2.80 and a beta of 0.83. Danaher has a 52 week low of …

marketbeat.com

FAQs about Moderna (MRNA) Stock Price, News & Analysis - MarketBeat Coupon?

How much did Moderna (mRNA) earnings beat analysts' estimate?

In the previous quarter, Moderna (NASDAQ:MRNA) reported $0.03 earnings per share (EPS) to beat the analysts' consensus estimate of ($1.89) by $1.92. Learn more on analysts' earnings estimate vs. MRNA's actual earnings. How can I listen to Moderna's earnings conference call? ...

What is the market capitalization of Moderna (mRNA)?

The market capitalization range for U.S. mid-caps typically falls between $1 billion and $8 billion and represents 20% of the total capitalization of the U.S. equity market. Find the latest Moderna, Inc. (MRNA) stock quote, history, news and other vital information to help you with your stock trading and investing. ...

What is the target price for Moderna stock?

The 17 analysts with 12-month price forecasts for Moderna stock have an average target of 76.35, with a low estimate of 38 and a high estimate of 139. The average target predicts an increase of 112.73% from the current stock price of 35.89. The average analyst rating for Moderna stock from 20 stock analysts is "Hold". ...

Will Moderna (mRNA) stock remain under scrutiny on Tuesday?

Moderna (MRNA) shares will likely remain under scrutiny on Tuesday after plunging nearly 17% Monday as the embattled drug maker slashed its 2025 revenue forecast by $1 billion. This article will provide an in-depth analysis of drugs being developed to combat cancer. ...

Why is Moderna (mRNA) stock trading higher?

Tuesday, Moderna Inc MRNA stock is trading higher with a session volume of 8.0 million as per data from Benzinga Pro. Shares of Moderna (MRNA) took off Tuesday when the biotech firm announced that the U.S. government has awarded it more than a half a billion dollars to develop a vaccine that can be used against bird ... ...

Is Moderna a good stock to buy now?

For Moderna, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +3.26%. On the other hand, the stock currently carries a Zacks Rank of #3. ...